39
Participants
Start Date
January 17, 2025
Primary Completion Date
January 30, 2026
Study Completion Date
January 30, 2027
VEN + DEC
"Induction regimen~Venetoclax (VEN): Day1-10~Decitabine (DEC):20mg/m²/day, Day 2-4~20mg/m² every 8 hours, Day 5-6~FLT3 Inhibitors (for FLT3/ITD+ patients only):~Sorafenib or Gilteritinib, Day 8-14~Post-Remission Treatment~Venetoclax (VEN): 400 mg/day, Day 1-7~Decitabine (DEC): 20 mg/m² every 8 hours, Day 2-3 (Regimen repeated every 4-6 weeks)~FLT3 Inhibitors (for FLT3/ITD+ patients only):~Sorafenib or Gilteritinib, Day 8-14"
RECRUITING
The Second Hospital of Hebei Medical University, Hebei
Handan First Hospital
OTHER
The Second Hospital of Hebei Medical University
OTHER